These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 23250130)

  • 41. Childhood Attention-Deficit/Hyperactivity Disorder Prescribing by Prescriber Type and Specialty in Oregon Medicaid.
    Klein TA; Panther S; Woo T; Odom-Maryon T; Daratha K
    J Child Adolesc Psychopharmacol; 2016 Aug; 26(6):548-54. PubMed ID: 27135134
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Current psychotropic medication prescribing patterns in late-life bipolar disorder.
    Rej S; Herrmann N; Shulman K; Fischer HD; Fung K; Gruneir A
    Int J Geriatr Psychiatry; 2017 Dec; 32(12):1459-1465. PubMed ID: 27911003
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Challenges in multiple sclerosis care: Results from an international mixed-methods study.
    Péloquin S; Schmierer K; Leist TP; Oh J; Murray S; Lazure P
    Mult Scler Relat Disord; 2021 May; 50():102854. PubMed ID: 33690086
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative effectiveness of dimethyl fumarate versus fingolimod and teriflunomide among MS patients switching from first-generation platform therapies in the US.
    Ontaneda D; Nicholas J; Carraro M; Zhou J; Hou Q; Babb J; Riester K; Mendoza JP; Livingston T; Jhaveri M
    Mult Scler Relat Disord; 2019 Jan; 27():101-111. PubMed ID: 30368221
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Examining the effects of comorbidities on disease-modifying therapy use in multiple sclerosis.
    Zhang T; Tremlett H; Leung S; Zhu F; Kingwell E; Fisk JD; Bhan V; Campbell TL; Stadnyk K; Yu BN; Marrie RA;
    Neurology; 2016 Apr; 86(14):1287-1295. PubMed ID: 26944268
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multiple sclerosis: current and emerging disease-modifying therapies and treatment strategies.
    Wingerchuk DM; Carter JL
    Mayo Clin Proc; 2014 Feb; 89(2):225-40. PubMed ID: 24485135
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Survey of diagnostic and treatment practices for multiple sclerosis (MS) in Europe. Part 2: Progressive MS, paediatric MS, pregnancy and general management.
    Fernández O; Delvecchio M; Edan G; Fredrikson S; Giovannoni G; Hartung HP; Havrdova E; Kappos L; Pozzilli C; Soerensen PS; Tackenberg B; Vermersch P; Comi G
    Eur J Neurol; 2018 May; 25(5):739-746. PubMed ID: 29356206
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Multiple Sclerosis Treatment Optimization Program.
    Langer-Gould A; Cheng SC; Li BH; Kanter MH
    Ann Clin Transl Neurol; 2021 Nov; 8(11):2146-2154. PubMed ID: 34662494
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Implications of real-world adherence on cost-effectiveness analysis in multiple sclerosis.
    Brandes DW; Raimundo K; Agashivala N; Kim E
    J Med Econ; 2013; 16(4):547-51. PubMed ID: 23391123
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The impact of persistence with therapy on inpatient admissions and emergency room visits in the US among patients with multiple sclerosis.
    Thomas NP; Curkendall S; Farr AM; Yu E; Hurley D
    J Med Econ; 2016; 19(5):497-505. PubMed ID: 26706292
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Performance associated effect variations of public reporting in promoting antibiotic prescribing practice: a cluster randomized-controlled trial in primary healthcare settings.
    Tang Y; Liu C; Zhang X
    Prim Health Care Res Dev; 2017 Sep; 18(5):482-491. PubMed ID: 28606190
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Elderly patients in general practice: diagnoses, drugs and inappropriate prescriptions. A report from the Møre & Romsdal Prescription Study.
    Straand J; Rokstad KS
    Fam Pract; 1999 Aug; 16(4):380-8. PubMed ID: 10493709
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Healthcare resource use and relapses with fingolimod versus natalizumab for treating multiple sclerosis: a retrospective US claims database analysis.
    Bergvall N; Lahoz R; Reynolds T; Korn JR
    Curr Med Res Opin; 2014 Aug; 30(8):1461-71. PubMed ID: 24754349
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Price analysis of multiple sclerosis disease-modifying therapies marketed in the United States.
    Bin Sawad A; Seoane-Vazquez E; Rodriguez-Monguio R; Turkistani F
    Curr Med Res Opin; 2016 Nov; 32(11):1783-1788. PubMed ID: 27359262
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Drug-prescribing patterns among optometrists and nonophthalmologist physicians at a tertiary care centre in Kingston, Ontario.
    Johnson D; El-Defrawy SR; Hollands S; Hurst J; Law C; Li C; Baxter S; Campbell Ede L; Campbell RJ
    Can J Ophthalmol; 2016 Jun; 51(3):168-73. PubMed ID: 27316262
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical practice of immunosuppressive treatments in multiple sclerosis: results of a second international questionnaire.
    Hommes OR; Weiner HL
    J Neurol Sci; 2004 Aug; 223(1):65-7. PubMed ID: 15261563
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identifying clinically questionable psychotropic prescribing practices for medicaid recipients in new york state.
    Essock SM; Covell NH; Leckman-Westin E; Lieberman JA; Sederer LI; Kealey E; Finnerty MT
    Psychiatr Serv; 2009 Dec; 60(12):1595-602. PubMed ID: 19952148
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cognitive dysfunction in patients with multiple sclerosis treated with different types of interferon beta: a randomized clinical trial.
    Mokhber N; Azarpazhooh A; Orouji E; Rao SM; Khorram B; Sahraian MA; Foroghipoor M; Gharavi MM; Kakhi S; Nikkhah K; Azarpazhooh MR
    J Neurol Sci; 2014 Jul; 342(1-2):16-20. PubMed ID: 24841321
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intervening to reduce the risk of future disability from multiple sclerosis: are we there yet?
    Dahdaleh M; Alroughani R; Aljumah M; AlTahan A; Alsharoqi I; Bohlega SA; Daif A; Deleu D; Inshasi J; Karabudak R; Sahraian MA; Taha K; Yammout BI; Zakaria M
    Int J Neurosci; 2017 Oct; 127(10):944-951. PubMed ID: 28029270
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diffusion of the new antiepileptic drug lamotrigine in Dutch clinical practice.
    Knoester PD; Belitser SV; Deckers CL; Keyser A; Renier WO; Egberts AC; Hekster YA
    Eur J Clin Pharmacol; 2004 Dec; 60(10):751-8. PubMed ID: 15619137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.